Literature DB >> 30070379

Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial.

Amit G Singal1,2,3,4, Jasmin A Tiro3,4, Caitlin C Murphy3,4, Jorge A Marrero1, Katharine McCallister3, Hannah Fullington3, Caroline Mejias3, Akbar K Waljee5,6,7, Wendy Pechero Bishop3,4, Noel O Santini1,2, Ethan A Halm1,2,3,4.   

Abstract

Hepatocellular carcinoma (HCC) surveillance is associated with early tumor detection and improved survival in patients with cirrhosis; however, effectiveness is limited by underuse. We compared the effectiveness of mailed outreach and patient navigation strategies to increase HCC surveillance in a racially diverse cohort of patients with cirrhosis. We conducted a pragmatic randomized clinical trial comparing mailed outreach for screening ultrasound (n = 600), mailed outreach plus patient navigation (n = 600), or usual care with visit-based screening (n = 600) among 1800 patients with cirrhosis at a large safety-net health system from December 2014 to March 2017. Patients who did not respond to outreach invitations within 2 weeks received reminder telephone calls. Patient navigation included an assessment of barriers to surveillance and encouragement of surveillance participation. The primary outcome was HCC surveillance (abdominal imaging every 6 months) over an 18-month period. All 1800 patients were included in intention-to-screen analyses. HCC surveillance was performed in 23.3% of outreach/navigation patients, 17.8% of outreach-alone patients, and 7.3% of usual care patients. HCC surveillance was 16.0% (95% confidence interval [CI]: 12.0%-20.0%) and 10.5% (95% CI: 6.8%-14.2%) higher in outreach groups than usual care (P < 0.001 for both) and 5.5% (95% CI: 0.9%-10.1%) higher for outreach/navigation than outreach alone (P = 0.02). Both interventions increased HCC surveillance across predefined patient subgroups. The proportion of HCC patients detected at an early stage did not differ between groups; however, a higher proportion of patients with screen-detected HCC across groups had early-stage tumors than those with HCC detected incidentally or symptomatically (83.3% versus 30.8%, P = 0.003).
Conclusion: Mailed outreach invitations and navigation significantly increased HCC surveillance versus usual care in patients with cirrhosis.
© 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2018        PMID: 30070379      PMCID: PMC6324997          DOI: 10.1002/hep.30129

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  34 in total

Review 1.  Toward a system of cancer screening in the United States: trends and opportunities.

Authors:  Nancy Breen; Helen I Meissner
Journal:  Annu Rev Public Health       Date:  2005       Impact factor: 21.981

Review 2.  Epidemiology of viral hepatitis and hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

Review 3.  Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review.

Authors:  Amit G Singal; Adam Yopp; Celette S Skinner; Milton Packer; William M Lee; Jasmin A Tiro
Journal:  J Gen Intern Med       Date:  2012-01-04       Impact factor: 5.128

4.  Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma.

Authors:  Amit G Singal; Michael L Volk; Mina O Rakoski; Sherry Fu; Grace L Su; Heather McCurdy; Jorge A Marrero
Journal:  J Clin Gastroenterol       Date:  2011-09       Impact factor: 3.062

5.  The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.

Authors:  Mustafa S Ascha; Ibrahim A Hanouneh; Rocio Lopez; Tarek Abu-Rajab Tamimi; Ariel F Feldstein; Nizar N Zein
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

6.  Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

Authors:  Franco Trevisani; Stefania De Notariis; Gianludovico Rapaccini; Fabio Farinati; Luisa Benvegnù; Marco Zoli; Gian Luca Grazi; Poggio Paolo Del; NolfoMariaAnna Di; Mauro Bernardi
Journal:  Am J Gastroenterol       Date:  2002-03       Impact factor: 10.864

7.  Failure rates in the hepatocellular carcinoma surveillance process.

Authors:  Amit G Singal; Adam C Yopp; Samir Gupta; Celette Sugg Skinner; Ethan A Halm; Eucharia Okolo; Mahendra Nehra; William M Lee; Jorge A Marrero; Jasmin A Tiro
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-30

8.  Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

Authors:  Anna S Lok; Leonard B Seeff; Timothy R Morgan; Adrian M di Bisceglie; Richard K Sterling; Teresa M Curto; Gregory T Everson; Karen L Lindsay; William M Lee; Herbert L Bonkovsky; Jules L Dienstag; Marc G Ghany; Chihiro Morishima; Zachary D Goodman
Journal:  Gastroenterology       Date:  2008-09-18       Impact factor: 22.682

9.  Randomized controlled trial of screening for hepatocellular carcinoma.

Authors:  Bo-Heng Zhang; Bing-Hui Yang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

10.  Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.

Authors:  Avo Artinyan; Brian Mailey; Nicelio Sanchez-Luege; Joshua Khalili; Can-Lan Sun; Smita Bhatia; Lawrence D Wagman; Nicholas Nissen; Steven D Colquhoun; Joseph Kim
Journal:  Cancer       Date:  2010-03-01       Impact factor: 6.860

View more
  23 in total

Review 1.  Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.

Authors:  Fasiha Kanwal; Amit G Singal
Journal:  Gastroenterology       Date:  2019-04-12       Impact factor: 22.682

2.  The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers.

Authors:  Elliot B Tapper; Shengchen Hao; Menghan Lin; John N Mafi; Heather McCurdy; Neehar D Parikh; Anna S Lok
Journal:  Hepatology       Date:  2019-06-21       Impact factor: 17.425

Review 3.  Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?

Authors:  Nicole E Rich; Amit G Singal
Journal:  Hepatology       Date:  2022-01-18       Impact factor: 17.425

Review 4.  Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.

Authors:  Lisa X Deng; Neil Mehta
Journal:  Dig Dis Sci       Date:  2020-12       Impact factor: 3.199

5.  Patient and provider-level barriers to hepatitis C screening and linkage to care: A mixed-methods evaluation.

Authors:  Robin T Higashi; Mamta K Jain; Lisa Quirk; Nicole E Rich; Akbar K Waljee; Barbara J Turner; Simon Craddock Lee; Amit G Singal
Journal:  J Viral Hepat       Date:  2020-03-02       Impact factor: 3.728

Review 6.  Epidemiology and surveillance for hepatocellular carcinoma: New trends.

Authors:  Amit G Singal; Pietro Lampertico; Pierre Nahon
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

Review 7.  The Future of Quality Improvement for Cirrhosis.

Authors:  Elliot B Tapper; Neehar D Parikh
Journal:  Liver Transpl       Date:  2021-07-31       Impact factor: 6.112

Review 8.  Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda.

Authors:  Amit G Singal; Anna S Lok; Ziding Feng; Fasiha Kanwal; Neehar D Parikh
Journal:  Clin Gastroenterol Hepatol       Date:  2020-09-19       Impact factor: 11.382

9.  Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis.

Authors:  Amit G Singal; Jasmin A Tiro; Caitlin C Murphy; James-Michael Blackwell; Jennifer R Kramer; Aisha Khan; Yan Liu; Song Zhang; Jessica L Phillips; Ruben Hernaez
Journal:  Clin Gastroenterol Hepatol       Date:  2020-07-03       Impact factor: 11.382

10.  Depression and Anxiety Are Common Among Patients With Cirrhosis.

Authors:  Ruben Hernaez; Jennifer R Kramer; Aisha Khan; Jessica Phillips; Katharine McCallister; Kassie Chaffin; Adriana Portela Hernandez; Hannah Fullington; Cynthia Ortiz; James-Michael Blackwell; Adam Loewen; Yan Liu; Jasmin A Tiro; Simon C Lee; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2020-08-21       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.